Found: 13
Select item for more details and to access through your institution.
Next-generation sequencing reveals the secrets of the chronic lymphocytic leukemia genome.
- Published in:
- Clinical & Translational Oncology, 2013, v. 15, n. 1, p. 3, doi. 10.1007/s12094-012-0922-z
- By:
- Publication type:
- Article
Is there a role for minimal residual disease monitoring in the management of patients with hairy‐cell leukaemia?
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 1, p. 127, doi. 10.1111/bjh.14900
- By:
- Publication type:
- Article
CD49d (ITGA4) expression is a predictor of time to first treatment in patients with chronic lymphocytic leukaemia and mutated IGHV status.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 1, p. 48, doi. 10.1111/bjh.13788
- By:
- Publication type:
- Article
POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia.
- Published in:
- Nature Genetics, 2013, v. 45, n. 5, p. 526, doi. 10.1038/ng.2584
- By:
- Publication type:
- Article
Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia.
- Published in:
- Nature Genetics, 2012, v. 44, n. 11, p. 1236, doi. 10.1038/ng.2443
- By:
- Publication type:
- Article
Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia.
- Published in:
- Nature Genetics, 2012, v. 44, n. 1, p. 47, doi. 10.1038/ng.1032
- By:
- Publication type:
- Article
Prognosis of patients with diffuse large B cell lymphoma not reaching complete response or relapsing after frontline chemotherapy or immunochemotherapy.
- Published in:
- Annals of Hematology, 2015, v. 94, n. 5, p. 803, doi. 10.1007/s00277-014-2271-1
- By:
- Publication type:
- Article
Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 12, p. 2037, doi. 10.1007/s00277-014-2152-7
- By:
- Publication type:
- Article
Relationship between the 46/1 haplotype of the JAK2 gene and the JAK2 mutational status and allele burden, the initial findings, and the survival of patients with myelofibrosis.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 5, p. 797, doi. 10.1007/s00277-013-1989-5
- By:
- Publication type:
- Article
Efficacy and tolerability of hydroxyurea in the treatment of the hyperproliferative manifestations of myelofibrosis: results in 40 patients.
- Published in:
- Annals of Hematology, 2010, v. 89, n. 12, p. 1233, doi. 10.1007/s00277-010-1019-9
- By:
- Publication type:
- Article
Clinicobiological Characteristics and Outcomes of Patients with T-Cell Large Granular Lymphocytic Leukemia and Chronic Lymphoproliferative Disorder of Natural Killer Cells from a Single Institution.
- Published in:
- Cancers, 2021, v. 13, n. 15, p. 3900, doi. 10.3390/cancers13153900
- By:
- Publication type:
- Article
Genetic and phenotypic characterisation of HIV‐associated aggressive B‐cell non‐Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications.
- Published in:
- Histopathology, 2022, v. 81, n. 6, p. 826, doi. 10.1111/his.14798
- By:
- Publication type:
- Article
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 5, p. 429, doi. 10.1002/ajh.23973
- By:
- Publication type:
- Article